최고 DTB 팟캐스트 (2024)

1
Drug safety alerts, valproate safety (again) and a new contraceptive POP 31:09

1M ago31:09

31:09

In this podcast recorded in early March, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the April 2024 issue of DTB. They discuss the editorial that questions whether drug safety alerts are effective in changing practice and whether more needs to be done to implement safety recommendations (https://dtb.bmj.com/conten…

1
Protecting consumers, tramadol-warfarin interaction and very low calorie diets 27:07

2M ago27:07

27:07

In this podcast recorded in early February, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the March 2024 issue of DTB. They discuss the editorial highlighting the important work that the founders of The Medical Letter, Worst Pills, Best Pills and Drug and Therapeutics Bulletin did to scrutinise the safety of medicin…

1
ADHD medicines shortages, fluoroquinolone safety, drugs not to prescribe 26:53

3M ago26:53

26:53

In this podcast recorded in early January, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the February 2024 issue of DTB. They discuss the editorial that highlights problems associated with shortages of ADHD medicines. They talk about two safety alerts issued by the Medicines and Healthcare products Regulatory Agency…

1
Continuity of care, statins and myasthenia gravis, and acne 17:17

4M ago17:17

17:17

In this podcast recorded in BMA House in December, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the January 2024 issue of DTB. They discuss continuity of care in general practice and the benefits it offers (https://dtb.bmj.com/content/62/1/2). They discuss a safety alert issued by the Medicines and Healthcare produ…

1
Rationalising blood tests, bempedoic acid and CV outcomes and semaglutide for obesity 26:40

5M ago26:40

26:40

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December 2023 issue of DTB. They discuss monitoring drugs in primary care and the need to rationalise the number of blood tests undertaken (https://dtb.bmj.com/content/61/12/178). They talk about a study that reported the effect of bempedoic acid on …

1
BNF moving with the times; preventable deaths; plus an intro to pharmacogenetics 20:05

6M ago20:05

20:05

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November 2023 issue of DTB. They discuss the history of the BNF and the announcement that the 86th edition of the BNF and the 2023–2024 edition of the BNF for Children will be the last print issues to be purchased by the National Institute for Health…

1
Taxing ill health, and what evidence for intravenous vitamins? 16:48

7M ago16:48

16:48

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2023 issue of DTB. They discuss NHS prescription charges in England and the impact they have on people with long-term ill health (https://dtb.bmj.com/content/61/10/146). They talk about a study that assessed the incidence of retinopathy assoc…

1
NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity 28:23

8M ago28:23

28:23

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2023 issue of DTB. They discuss concerns over redacted data in NICE appraisal documents (https://dtb.bmj.com/content/61/9/130). They review a placebo-controlled study that assessed the use of spironolactone for women with acne (https://dtb.…